Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages

P. Whitley, Heather; Trujillo, Jennifer; J. Neumiller, Joshua

doi:10.2337/cd23-0023

Public

Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages

Published in Clinical Diabetes • Apr 7, 2023

Authors:

Heather P. Whitley

Jennifer Trujillo

Joshua J. Neumiller

Abstract

Unexpected drug shortages of the long-acting glucagon-like peptide-1 (GLP-1) receptor agonists dulaglutide and semaglutide and the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide emerged in late 2022 and have persisted through the first quarter of 2023 (1)....

Subject

Agonist

Medicine

Glucagon-like peptide 1 receptor

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!